Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Careers Booklet

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 15 July 1988:
Vol. 241. no. 4863, pp. 353 - 357
DOI: 10.1126/science.2838909
Prev | Table of Contents | Next

Articles

Science, Vol 241, Issue 4863, 353-357
Copyright © 1988 by American Association for the Advancement of Science

articles

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC

JW Harbour, SL Lai, J Whang-Peng, AF Gazdar, JD Minna, and FJ Kaye

Howard Hughes Medical Institute, Bethesda, MD 20814.

Small cell lung cancer (SCLC) has been associated with loss of heterozygosity at several distinct genetic loci including chromosomes 3p, 13q, and 17p. To determine whether the retinoblastoma gene (Rb) localized at 13q14, might be the target of recessive mutations in lung cancer, eight primary SCLC tumors and 50 cell lines representing all major histologic types of lung cancer were examined with the Rb complementary DNA probe. Structural abnormalities within the Rb gene were observed in 1/8 (13%) primary SCLC tumors, 4/22 (18%) SCLC lines, and 1/4 (25%) pulmonary carcinoid lines (comparable to the 20 to 40% observed in retinoblastoma), but were not detected in other major types of lung cancer. Rb messenger RNA expression was absent in 60% of the SCLC lines and 75% of pulmonary carcinoid lines, including all samples with DNA abnormalities. In contrast, Rb transcripts were found in 90% of non-SCLC lung cancer lines and in normal human lung. The finding of abnormalities of the Rb gene in SCLC and pulmonary carcinoids (both neuroendocrine tumors) suggests that this gene may be involved in the pathogenesis of a common adult malignancy.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Small Molecule Disruptor of Rb/Raf-1 Interaction Inhibits Cell Proliferation, Angiogenesis, and Growth of Human Tumor Xenografts in Nude Mice.
R. Kinkade, P. Dasgupta, A. Carie, D. Pernazza, M. Carless, S. Pillai, N. Lawrence, S. M. Sebti, and S. Chellappan (2008)
Cancer Res. 68, 3810-3818
   Abstract »    Full Text »    PDF »
Selective Requirements for E2f3 in the Development and Tumorigenicity of Rb-Deficient Chimeric Tissues.
T. Parisi, T. L. Yuan, A. M. Faust, A. M. Caron, R. Bronson, and J. A. Lees (2007)
Mol. Cell. Biol. 27, 2283-2293
   Abstract »    Full Text »    PDF »
Eye Cancer: Unique Insights into Oncogenesis The Cogan Lecture.
J. W. Harbour (2006)
Invest. Ophthalmol. Vis. Sci. 47, 1737-1745
   Full Text »    PDF »
The Retinoblastoma Protein Is Required for Ras-Induced Oncogenic Transformation.
J. P. Williams, T. Stewart, B. Li, R. Mulloy, D. Dimova, and M. Classon (2006)
Mol. Cell. Biol. 26, 1170-1182
   Abstract »    Full Text »    PDF »
Tumor suppressor genetics.
S. R. Payne and C. J. Kemp (2005)
Carcinogenesis 26, 2031-2045
   Abstract »    Full Text »    PDF »
Pathogenesis of Lung Cancer: 100 Year Report.
Y. E. Miller (2005)
Am. J. Respir. Cell Mol. Biol. 33, 216-223
   Abstract »    Full Text »    PDF »
Smad7 Abrogates Transforming Growth Factor-{beta}1-mediated Growth Inhibition in COLO-357 Cells through Functional Inactivation of the Retinoblastoma Protein.
N. Boyer Arnold and M. Korc (2005)
J. Biol. Chem. 280, 21858-21866
   Abstract »    Full Text »    PDF »
Liver-Specific pRB Loss Results in Ectopic Cell Cycle Entry and Aberrant Ploidy.
C. N. Mayhew, E. E. Bosco, S. R. Fox, T. Okaya, P. Tarapore, S. J. Schwemberger, G. F. Babcock, A. B. Lentsch, K. Fukasawa, and E. S. Knudsen (2005)
Cancer Res. 65, 4568-4577
   Abstract »    Full Text »    PDF »
Differential role of RB in response to UV and IR damage.
E. E. Bosco and E. S. Knudsen (2005)
Nucleic Acids Res. 33, 1581-1592
   Abstract »    Full Text »    PDF »
Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130.
J.-H. Dannenberg, L. Schuijff, M. Dekker, M. van der Valk, and H. t. Riele (2004)
Genes & Dev. 18, 2952-2962
   Abstract »    Full Text »    PDF »
Carcinogen exposure differentially modulates RAR-{beta} promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis.
B. R. Vuillemenot, L. C. Pulling, W. A. Palmisano, J. A. Hutt, and S. A. Belinsky (2004)
Carcinogenesis 25, 623-629
   Abstract »    Full Text »    PDF »
Ras Protects Rb Family Null Fibroblasts from Cell Death: A ROLE FOR AP-1.
A. P. Young and G. D. Longmore (2004)
J. Biol. Chem. 279, 10931-10938
   Abstract »    Full Text »    PDF »
For Whom the Bell Tolls: Susceptibility to Common Adult Cancers in Retinoblastoma Survivors.
F. J. Kaye and J. W. Harbour (2004)
J Natl Cancer Inst 96, 342-343
   Full Text »    PDF »
Noninvasive Imaging of Spontaneous Retinoblastoma Pathway-dependent Tumors in Mice.
M. Vooijs, J. Jonkers, S. Lyons, and A. Berns (2002)
Cancer Res. 62, 1862-1867
   Abstract »    Full Text »    PDF »
Molecular Basis of Low-Penetrance Retinoblastoma.
J. W. Harbour (2001)
Arch Ophthalmol 119, 1699-1704
   Abstract »    Full Text »    PDF »
p53 and p21waf-1 Expression Correlates with Apoptosis or Cell Survival in Poorly Differentiated, but not Well-Differentiated, Retinoblastomas.
A. Divan, J. Lawry, I. R. Dunsmore, M. A. Parsons, and J. A. Royds (2001)
Cancer Res. 61, 3157-3163
   Abstract »    Full Text »
Protective Function of p27KIP1 against Apoptosis in Small Cell Lung Cancer Cells in Unfavorable Microenvironments.
A. Masuda, H. Osada, Y. Yatabe, K.-i. Kozaki, Y. Tatematsu, T. Takahashi, T. Hida, T. Takahashi, and T. Takahashi (2001)
Am. J. Pathol. 158, 87-96
   Abstract »    Full Text »    PDF »
Hereditary Retinoblastoma and Risk of Lung Cancer.
R. A. Kleinerman, R. E. Tarone, D. H. Abramson, J. M. Seddon, F. P. Li, and M. A. Tucker (2000)
J Natl Cancer Inst 92, 2037-2039
   Full Text »    PDF »
Ablation of the Retinoblastoma gene family deregulates G1 control causing immortalization and increased cell turnover under growth-restricting conditions.
J.-H. Dannenberg, A. van Rossum, L. Schuijff, and H. te Riele (2000)
Genes & Dev. 14, 3051-3064
   Abstract »    Full Text »
Deregulation of the Rb and p53 Pathways in Uveal Melanoma.
M. A. Brantley Jr. and J. W. Harbour (2000)
Am. J. Pathol. 157, 1795-1801
   Abstract »    Full Text »    PDF »
The 630-kb Lung Cancer Homozygous Deletion Region on Human Chromosome 3p21.3: Identification and Evaluation of the Resident Candidate Tumor Suppressor Genes.
M. I. Lerman and J. D. Minna (2000)
Cancer Res. 60, 6116-6133
   Abstract »    Full Text »
p16Ink4a Tumor Suppressor Function in Lung Cancer Cells Involves Cyclin-dependent Kinase 2 Inhibition by Cip/Kip Protein Redistribution.
B. Grimison, T. A. Langan, and R. A. Sclafani (2000)
Cell Growth Differ. 11, 507-515
   Abstract »    Full Text »
The Rb/E2F pathway: expanding roles and emerging paradigms.
J. W. Harbour and D. C. Dean (2000)
Genes & Dev. 14, 2393-2409
   Full Text »
Molecular and Genetic Aspects of Lung Cancer.
W. N. ROM, J. G. HAY, T. C. LEE, Y. JIANG, and K.-M. TCHOU-WONG (2000)
Am. J. Respir. Crit. Care Med. 161, 1355-1367
   Full Text »
MOLECULAR PATHOGENESIS OF LUNG CANCER.
K. M. Fong, Y. Sekido, and J. D. Minna (1999)
J. Thorac. Cardiovasc. Surg. 118, 1136-1152
   Abstract »    Full Text »    PDF »
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers.
Y.-C. Lee, Y.-L. Chang, S.-P. Luh, J.-M. Lee, and J.-S. Chen (1999)
Ann. Thorac. Surg. 68, 343-347
   Abstract »    Full Text »    PDF »
How many tumor suppressor genes are involved in human lung carcinogenesis?.
T. Kohno and J. Yokota1 (1999)
Carcinogenesis 20, 1403-1410
   Abstract »    Full Text »    PDF »
Prognostic Significance of Allelic Imbalances on Chromosome 9p in Stage I Non-Small Cell Lung Carcinoma.
Y. Tomizawa, J.-i. Adachi, T. Kohno, K. Hamada, R. Saito, M. Noguchi, Y. Matsuno, S. Hirohashi, N. Yamaguchi, and J. Yokota (1999)
Clin. Cancer Res. 5, 1139-1146
   Abstract »    Full Text »    PDF »
The Molecular Pathogenesis of Corticotroph Tumors.
P. L. M. Dahia and A. B. Grossman (1999)
Endocr. Rev. 20, 136-155
   Abstract »    Full Text »
Urinary Bladder Transitional Cell Carcinogenesis Is Associated with Down-Regulation of NF1 Tumor Suppressor Gene in Vivo and in Vitro.
V. Aaltonen, P. J. Bostrom, K.-O. Soderstrom, O. Hirvonen, J. Tuukkanen, M. Nurmi, M. Laato, and J. Peltonen (1999)
Am. J. Pathol. 154, 755-765
   Abstract »    Full Text »    PDF »
Recruitment of the Retinoblastoma Protein to c-Jun Enhances Transcription Activity Mediated through the AP-1 Binding Site.
J. Nishitani, T. Nishinaka, C.-H. Cheng, W. Rong, K. K. Yokoyama, and R. Chiu (1999)
J. Biol. Chem. 274, 5454-5461
   Abstract »    Full Text »    PDF »
p107 is a suppressor of retinoblastoma development in pRb-deficient mice.
E. Robanus-Maandag, M. Dekker, M. van der Valk, M.-L. Carrozza, J.-C. Jeanny, J.-H. Dannenberg, A. Berns, and H. te Riele (1998)
Genes & Dev. 12, 1599-1609
   Abstract »    Full Text »
Novel Mechanisms of E2F Induction by BK Virus Large-T Antigen: Requirement of Both the pRb-Binding and the J Domains.
K. F. Harris, J. B. Christensen, E. H. Radany, and M. J. Imperiale (1998)
Mol. Cell. Biol. 18, 1746-1756
   Abstract »    Full Text »
Mechanism of Retinoblastoma Gene Inactivation in the Spectrum of Neuroendocrine Lung Tumors.
V. GOUYER, S. GAZZéRI, I. BOLON, C. DREVET, C. BRAMBILLA, and E. BRAMBILLA (1998)
Am. J. Respir. Cell Mol. Biol. 18, 188-196
   Abstract »    Full Text »
Mutation Analysis of Glial Cell Line-Derived Neurotrophic Factor, a Ligand for an RET/Coreceptor Complex, in Multiple Endocrine Neoplasia Type 2 and Sporadic Neuroendocrine Tumors.
D. J. Marsh, Z. Zheng, A. Arnold, S. D. Andrew, D. Learoyd, A. Frilling, P. Komminoth, H. P.H. Neumann, B. A.J. Ponder, B. J. Rollins, et al. (1997)
J. Clin. Endocrinol. Metab. 82, 3025-3028
   Abstract »    Full Text »    PDF »
The p120-v-Abl Protein Interacts with E2F-1 and Regulates E2F-1 Transcriptional Activity.
M. C. Birchenall-Roberts, Y. D. Yoo, D. C. Bertolette III, K.-H. Lee, J. M. Turley, O.-S. Bang, F. W. Ruscetti, and S.-J. Kim (1997)
J. Biol. Chem. 272, 8905-8911
   Abstract »    Full Text »    PDF »
Targeted disruption of p107: functional overlap between p107 and Rb..
M H Lee, B O Williams, G Mulligan, S Mukai, R T Bronson, N Dyson, E Harlow, and T Jacks (1996)
Genes & Dev. 10, 1621-1632
   Abstract »    PDF »
Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53..
K A Howes, N Ransom, D S Papermaster, J G Lasudry, D M Albert, and J J Windle (1994)
Genes & Dev. 8, 1300-1310
   Abstract »    PDF »
Multistep carcinogenesis: a 1992 perspective.
T Sugimura (1992)
Science 258, 603-607
   Abstract »    PDF »
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F..
S W Hiebert, S P Chellappan, J M Horowitz, and J R Nevins (1992)
Genes & Dev. 6, 177-185
   Abstract »    PDF »
Tumor suppressor genes.
R. Weinberg (1991)
Science 254, 1138-1146
   Abstract »    PDF »
Expression of the Wilms' tumor gene WT1 in the murine urogenital system..
J Pelletier, M Schalling, A J Buckler, A Rogers, D A Haber, and D Housman (1991)
Genes & Dev. 5, 1345-1356
   Abstract »    PDF »
Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.
R Bookstein, J. Shew, P. Chen, P Scully, and W. Lee (1990)
Science 247, 712-715
   Abstract »    PDF »
p53: oncogene or anti-oncogene?.
D P Lane and S Benchimol (1990)
Genes & Dev. 4, 1-8
   PDF »
Tumor suppressor genes: the puzzle and the promise.
R Sager (1989)
Science 246, 1406-1412
   Abstract »    PDF »
Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product.
K Mihara, X. Cao, A Yen, S Chandler, B Driscoll, A. Murphree, A T'Ang, and Y. Fung (1989)
Science 246, 1300-1303
   Abstract »    PDF »
p53: a frequent target for genetic abnormalities in lung cancer.
T Takahashi, M. Nau, I Chiba, M. Birrer, R. Rosenberg, M Vinocour, M Levitt, H Pass, A. Gazdar, and J. Minna (1989)
Science 246, 491-494
   Abstract »    PDF »
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.
N Dyson, P. Howley, K Munger, and E Harlow (1989)
Science 243, 934-937
   Abstract »    PDF »
Point mutational inactivation of the retinoblastoma antioncogene.
J. Horowitz, D. Yandell, S. Park, S Canning, P Whyte, K Buchkovich, E Harlow, R. Weinberg, and T. Dryja (1989)
Science 243, 937-940
   Abstract »    PDF »
Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.
H. Huang, J. Yee, J. Shew, P. Chen, R Bookstein, T Friedmann, E. Lee, and W. Lee (1988)
Science 242, 1563-1566
   Abstract »    PDF »
Identification of germline and somatic mutations affecting the retinoblastoma gene.
J. Dunn, R. Phillips, A. Becker, and B. Gallie (1988)
Science 241, 1797-1800
   Abstract »    PDF »
ANTI-ONCOGENES AND CANCER: STARTLING NEW INSIGHTS.
(1988)
Journal Watch (General) 1988, 6
   Full Text »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)